restor3d, the future of personalized orthopedic procedures, closed the acquisition of Conformis on August 31, 2023
On August 31, 2023, the shareholders of Conformis, Inc. voted to approve the acquisition of Conformis by restor3d, which officially closes the transaction.
As a result, Conformis is no longer a standalone publicly-traded company whose common shares are available on the NASDAQ stock exchange. Instead, Conformis is now fully-owned by privately held restor3d, and Conformis is restor3d’s product line for knee and hip replacement implants.
With the addition of Conformis, restor3d has boosted its position as the future of personalized orthopedic procedures, covering knees, hips, shoulders and ankles.
To learn more about restor3d, please visit our web site here.